Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lingze tablet for benign prostatic hyperplasia in community hospitals (real-world)
ChiCTR2000033634Phase 4Recruiting
- Sponsor
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
- Start
- Jun 2020
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Lingze in benign prostatic hyperplasia (BPH), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Primary endpoints: B-mode ultrasonography, prostate-specific antigen (PSA) and 3 more. Started Jun 2020; status: recruiting.
02
Drugs
Lingze
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on ChiCTR2000033634.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033634.